Back
Goldman Sachs ActiveBeta US Large Cap Equity ETF Vs. Nektar Therapeutics Industry Stock Comparison
Buy
72
GSLC
Goldman Sachs ActiveBeta US Large Cap Equity ETF
Last Price:
$130.82
Seasonality Move:
3.87%
Sell
42
NKTR
Nektar Therapeutics
Last Price:
$44.63
Seasonality Move:
11.58%
Buy
72
Goldman Sachs ActiveBeta US Large Cap Equity ETF (GSLC)
is a Buy
Is Goldman Sachs ActiveBeta US Large Cap Equity ETF a Buy, Sell or Hold?
-
The current Goldman Sachs ActiveBeta US Large Cap Equity ETF [GSLC] share price is $131.82. The Score for GSLC is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
-
GSLC is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
42
Nektar Therapeutics (NKTR)
is a Sell
Is Nektar Therapeutics a Buy, Sell or Hold?
-
The current Nektar Therapeutics [NKTR] share price is $49.16. The Score for NKTR is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
NKTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GSLC Stock Price Chart
What is Goldman Sachs ActiveBeta US Large Cap Equity ETF's stock price today?
-
The Goldman Sachs ActiveBeta US Large Cap Equity ETF share price today is $131.82The current trend is moderately bearish and GSLC is experiencing slight buying pressure.
NKTR Stock Price Chart
What is Nektar Therapeutics's stock price today?
-
The Nektar Therapeutics share price today is $49.16Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing slight buying pressure.
GSLC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.68 | Buy |
| Relative Strength Index (14 RSI): | 51.61 | Buy |
| Chaikin Money Flow: | 60471 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
NKTR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.43 | Sell |
| Relative Strength Index (14 RSI): | 38.92 | Sell |
| Chaikin Money Flow: | 341847 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
GSLC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 132.67 | Sell |
| 20-day SMA: | 131.19 | Buy |
| 50-day SMA: | 130.83 | Buy |
| 200-day SMA: | 121.54 | Buy |
| 8-day EMA: | 132.36 | Sell |
| 20-day EMA: | 131.79 | Buy |
| 50-day EMA: | 128.32 | Buy |
| 200-day EMA: | 81.01 | Buy |
NKTR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 54.87 | Sell |
| 20-day SMA: | 57.43 | Sell |
| 50-day SMA: | 58.05 | Sell |
| 200-day SMA: | 31.04 | Buy |
| 8-day EMA: | 54.11 | Sell |
| 20-day EMA: | 56.28 | Sell |
| 50-day EMA: | 55.42 | Sell |
| 200-day EMA: | 38.13 | Buy |
Goldman Sachs ActiveBeta US Large Cap Equity ETF Earnings Growth & GSLC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Nektar Therapeutics Earnings Growth & NKTR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.
Goldman Sachs ActiveBeta US Large Cap Equity ETF Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Nektar Therapeutics Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||